Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.96 USD | -0.02% | +0.22% | +240.82% |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.82% | 4.46B | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.29% | 22.28B | |
-5.52% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- ALPN Stock
- News Alpine Immune Sciences, Inc.
- Wolfe Research Downgrades Alpine Immune Sciences to Peer Perform From Outperform